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0022-2836/$ - see front matter © 2008 EPoxviruses have evolved numerous strategies to evade host innate immu-
nity. Vaccinia virus K7 is a 149-residue protein with previously unknown
structure that is highly conserved in the orthopoxvirus family. K7 bears
sequence and functional similarities to A52, which interacts with interleukin
receptor-associated kinase 2 and tumor necrosis factor receptor-associated
factor 6 to suppress nuclear factor κB activation and to stimulate the se-
cretion of the anti-inflammatory cytokine interleukin-10. In contrast to A52,
K7 forms a complex with DEAD box RNA helicase DDX3, thereby sup-
pressing DDX3-mediated ifnb promoter induction. We determined the NMR
solution structure of K7 to provide insight into the structural basis for
poxvirus antagonism of innate immune signaling. The structure reveals an
α-helical fold belonging to the Bcl-2 family despite an unrelated primary
sequence. NMR chemical-shift mapping studies have localized the binding
surface for DDX3 on a negatively charged face of K7. Furthermore, ther-
modynamic studies have mapped the K7-binding region to a 30-residue
N-terminal fragment of DDX3, ahead of the core RNA helicase domains.© 2008 Elsevier Ltd. All rights reserved.Keywords: K7 protein; DDX3 helicase; Bcl-2; nuclear magnetic resonance
(NMR) spectroscopy; innate immunityEdited by A. G. Palmer IIIIntroduction
Poxviruses are large double-strandedDNAviruses
encoding ∼200 genes that replicate in the cytoplasm
of host cells.1 Members of this family include
vaccinia (VACV) and variola virus, the causative
agent of smallpox. In addition to viral RNA/DNA
polymerases and virion assembly proteins, poxvi-
ruses encode proteins such as A46 and A52 that
antagonize host immunity. Previous studies of pox-resses:
ac.uk.
ually to this work.
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lsevier Ltd. All rights reservevirus antagonism of immune signaling were ins-
trumental in revealing the critical role of Toll-like
receptors (TLRs) in the antiviral state.2 Originally
identified as mediators of innate immunity against
bacterial pathogens, TLRs are a family of single-span
membrane proteins whose extracellular regions
consist of leucine-rich repeats that bind pathogen-
associated molecular patterns such as lipopolysac-
charides and double-stranded RNA.3 Recent crystal
structures of the ectodomain of TLRs alone and in
complex with a triglyceride agonist suggest a model
for oligomerization that triggers a complex intracel-
lular signaling cascade leading to nuclear factor κB
(NF-κB) activation, altered gene expression and in-
flammation.4 Inappropriate activation of TLRs is
implicated in a variety of pathological conditions,
such as autoimmune disease (arthritis, asthma, sys-
temic lupus erythromatosis), the allergic reaction,
sepsis and type I diabetes.5
Biochemical and cellular studies of two VACV pro-
teins, A46 and A52, revealed that they contribute to
virulence by antagonizing TLR-dependent signaling
pathways.6,7 A52 interacts with components of thed.
Table 1. NMR and refinement statistics for protein
structures
K7(8–149)
NMR distance and dihedral constraints
Distance constraints
Total NOE 2892
Intraresidue 1440
Interresidue 1452
Sequential (|i–j|=1) 737
Medium-range (|i–j|≤4) 348
Long-range (|i–j|≥5) 367
Intermolecular
Total RDCs 71
1DHN 71
Total dihedral angle restraints 182
ϕ 91
ψ 91
Structure statistics
Violations (mean and s.d.)
Distance constraints (Å) 0.0234±0.0007
Dihedral angle constraints (°) 0.11±0.47
Max. dihedral angle violation (°) 6.123
Max. distance constraint violation (Å) 0.422
RDC Q 0.28±0.024
Average RDC violation (°) 0.60±0.80
Deviations from idealized geometry
Bond lengths (Å) 0.0062±0.00018
Bond angles (°) 0.71±0.02
Impropers (°) 1.71±0.09
Average pairwise rmsd⁎ (Å)
Heavy 0.750
Backbone 0.330
*Pairwise rmsd's were calculated over structured regions from an
ensemble of 15 structures superimposing the restrained residues
in the molecule (8–82, 95–115, 129–148).
844 Structure of K7TLR signaling cascade, namely, tumor necrosis factor
receptor-associated factor 6 (TRAF6) and interleukin
receptor-associated kinase 2 (IRAK2). Binding to
TRAF6 mediates p38 mitogen-activated protein
kinase activation and induction of the anti-inflamma-
tory cytokine interleukin-10, while the interaction
with IRAK2 leads to inhibition of both NF-κB acti-
vation and subsequent release of pro-inflammatory
cytokines.2 VACV protein K7 is highly conserved in
the poxvirus family and has 25% identity (50% homo-
logy) toA52. Both are also predicted to formpredomi-
nantly α-helices by secondary-structure algorithms.
Recent co-immunoprecipitation experiments in the
laboratory of one of the authors have shown that K7
also interacts with TRAF6 and IRAK2.8 However, in
striking contrast to A52, K7 forms a complex with
DEAD box RNA helicase DDX3.8
Functionally, RNA helicases are described as
adenosine triphosphate (ATP)-dependent motor
proteins that unwind double-stranded nucleic
acids.9 Structurally, RNAhelicases share a conserved
catalytic core that comprises tandem RecA-like
domains. The ATP-binding groove is mainly formed
by the N-terminal domain, but the mature catalytic
machinery involves an intimate association of the
two domains around the ATP pocket. The RNA bin-
ding site stretches across the two domains in the
active conformation of RNA helicases. The catalytic
machinery includes the eponymous ‘D-E-A-D/H’
sequence in ‘superfamily 2’ to which DDX3 belongs,
adjacent to the phosphate arm of ATP.10 Hydrolysis
of ATP is stimulated by cycles of binding and release
of RNA molecules.11 The biological functions of the
∼45 RNAhelicases in the human genome are diverse
and poorly characterized. They have been implicated
inmultiple aspects of RNAmetabolism at the level of
transcription, translation, messenger RNA (mRNA)
transport and stability. Indeed some of the functions
of RNA helicases may not be linked to enzymatic
activity at all. Recent structural and functional
studies of eIF4AIII, a component of the exon junction
complex, demonstrate that the RNAhelicase acts as a
‘placeholder’ for nascent RNA molecules and shut-
tles them from the nucleus to the cytosol.12 Outside
of the RecA-like domains, the sequences and domain
organization of RNA helicases are highly hetero-
genous in size and composition, likely reflecting their
diverse roles in cellular processes.
Both K7 and A52 bear no apparent sequence simi-
larities to proteins whose three-dimensional struc-
tures are known.Herewe describe theNMR solution
structure of K7 and map its interactions with DDX3
in order to gain insight into the molecular basis for
poxvirus antagonism of innate immune signaling.
Results
Solution structure of K7R
To determine the structure of K7 by NMR, we
chose to work on a fragment (K7Δ8, 8–149) that was
slightly truncated at the N-terminus (hereaftertermed K7), thus yielding considerably better NMR
spectra than the full-length construct. Using multi-
dimensional NMR spectroscopy, we obtained (1H,
13C, 15N) assignments of 135 out of 142 residues for
the backbone and 87%of the side-chain resonances of
K7. Cross peaks in the 1H–15N heteronuclear single
quantum coherence (HSQC) for one of the regions in
the protein (residues 116–128, α5–α6 loop) were
relatively weak. In this region, peaks for residues
F122, Q123, S124, L125 and I128 were missing from
the spectra and could not be assigned, suggesting
conformational exchange. Similarly, two residues
(N88 and H93) in the α3–α5 loop region could not be
assigned. This loop lacks an α-helical conformation,
in contrast to known structures of viral and cellular
B-cell lymphoma protein-2 (Bcl-2) family of proteins
(discussed below). Structures were calculated with
2892 nuclear Overhauser enhancement (NOE)
restraints, 182 dihedral angle restraints and 71 resi-
dual dipolar coupling (RDC) restraints (Table 1). For
the final ensemble of 15 structures, the rmsd of
backbone atoms from the mean structure was 0.33 Å
(Fig. 1 and Supplementary Fig. S1).
The overall fold of K7 consists of a bundle of six
α-helices and connecting loops that match the topo-
logy of the Bcl-2 family of proteins that regulate
apoptosis (Fig. 1). The structure of K7 closely resem-
bles the X-ray crystal structure of poxvirus proteinN1
Fig. 1. Solution structure of K7 and comparisons to the viral Bcl-2 family. (a) Best-fit superposition of 15 final structures
showing backbone bonds. (b) Ribbonmodel of the lowest-energy structure from the ensemble showing the six α-helices of
K7 with Bcl-2 topology labels. The secondary-structure regions are helix 1 (23–43), helix 2 (52–68), helix 3 (70–82), helix 5
(95–115), helix 6 (129–147) and helix 7 (134–147). The disordered regions correspond to residues 83–94 and 116–128 (α5–α6
loop). (c) Poxvirus N1 protein (PDB code 2i39) is the closest structural relative of K7. (d) Myxoma virus M11L protein
(yellow, PDB code 2jby) in complex with a 26-mer BH3 peptide from Bak (magenta). Coordinates of K7 have been
deposited in the Protein Database and BioMagResBank, accession numbers 2k36 and 15740, respectively. We have
maintained the canonical Bcl-2 nomenclature for the α-helices that follow loop 84–93 of K7 in order to avoid confusion in
discussions in the text.
845Structure of K7recently determined by two independent groups.13,14
The fold consists of a central α-helix (α5) surrounded
by a layer of additional α-helices. More important,
K7 is flexible and lacks secondary structure in the
region 84–93, which corresponds to α4 in all known
viral and cellular members of the Bcl-2 family. This
flexibility in K7 may have functional implications
(discussed below), since α4 in other viral Bcl-2
homologs forms one wall of a groove that binds to
pro-apoptotic BH3-containing proteins. We have
maintained the canonical Bcl-2 nomenclature for
the α-helices that follow loop 84–93 of K7 in order to
avoid confusion in the ensuing discussions.The 149-residue K7 has a lengthy prelude to the
first α-helix, relative to N1. This region (residues 8–
23) lacks regular secondary structure, and residues
8–11 show significant flexibility despite modest
interactions with α1 and the α1–α2 loop. Following
least-squares superposition using a secondary- struc-
turematching algorithm implemented inCCP4mg,15
K7 most closely resembles N1 (rmsd=2.38 Å for 101
Cα atoms). Upon superposition of K7 and Bcl-2
[Protein Data Bank (PDB) code 1PQ1], the rmsd for
90 Cα atoms is 3.8 Å. The N-terminal extension of K7
accounts for the difference in sequence length
between K7 (149 residues) versus N1 (115 residues).
Fig. 2. Structure-based sequence alignment of viral and cellular Bcl-2 family proteins. The green ribbons correspond to
K7, while grey ribbons mark the structure of N1. Residues conserved between K7 and A52 are highlighted in light and
dark green. Dashed lines are consecutive residues, while dots mark regions with insertions, with the major one in Bcl-xL
indicated by sequence numbers.
846 Structure of K7Myxoma virus protein M11L, whose structure was
determined in the absence and in the presence of the
BH3 peptide from Bak,16 is another member of the
extended family of viral Bcl-2 proteins. Finally, the
crystal structure of herpesvirus M11L was recently
determined in complex with a fragment of proauto-
phagic Beclin1.17 The structural similarities between
viral proteins K7, N1, M11 and M11L are striking
despite the lack of significant sequence identities
(Figs. 1 and 2).
K7 is a monomer with a closed BH3 groove
The Bcl-2 family of proteins regulate apoptotic
pathways by forming oligomeric complexes via the
presence of varying numbers of Bcl-2-homology
regions (BH1–BH4).18 For example, Bim (a BH3-only
protein) adopts an α-helical conformation in its BH3
segment and interacts with the hydrophobic grooveFig. 3. The BH3 groove of K7 is filled with hydrophobic s
coloured green, and N1 is grey. Side chains are represented as s
and F89 in K7. The N1 surface is relatively open, although Aron Bcl-xL, formed by α2, α3, α4 and the ‘NWGR’
motif at the beginning of α5.19 This groove is also
conserved in the two known structures of poxvirus
Bcl-2 family homologs, N1 and M11. The crystal
structure of M11L-Bak revealed that, in general, the
mode of binding was conserved despite sequence
differences, as exemplified by the lack of the cha-
racteristic NWGR motif.
Although the structure of N1 in complex with pro-
apoptotic Bcl-2 proteins has not yet been determined,
biochemical studies have confirmed thatN1 interacts
with Bad, Bax and Bid.13 Notably, hydrophobic resi-
dues in the presumed groove (Leu27, Leu52) are
conservedwith the Bcl-2 family. Following structural
alignment, the BH3 groove of N1 reveals an open
conformation that is poised for interactions with its
cognate proteins (Fig. 3). The hydrophobic dyad
corresponds to residues Leu57 and Ile76 in K7, im-
plying that a hydrophobic patch is conserved withinide chains. The orientation is the same as in Fig. 1. K7 is
tick models to emphasize BH3 groove closure by Y67, Y68,
g58 of α4 resides along one wall of the BH3 groove.
847Structure of K7this region. However, in striking contrast to the ex-
tended Bcl-2 family, the NMR structure of K7 reveals
a closed groove that is incompatible with binding of
α-helical BH3 domains (Fig. 3). Relative to N1, clo-
sure of the groove in K7 is a consequence of the
longer α2 helix and its orientation, which effectively
seals the pocket at the position where the C-terminal
end of the BH3 helix would reside. Thus, although
the residues flanking the groove are unstructured
and undergo picosecond–nanosecond and milli-
second dynamics, binding of BH3 domains would
require a major rearrangement of the side chains of
Y67 andY68 andmovement of the unstructured loop
82–94 away from the conformational space taken up
in the structure ensemble. In further contrast to N1,
K7 is a monomer in solution, forming a 1:1 stoichio-
metric complex with its effector DDX3 (Fig. S2).
Intriguingly, the segment Asp84–His93 appears to be
in conformational flux in K7, whereas other Bcl-2
family members adopt a helical conformation (α4)
that forms one wall of the BH3 groove. The sequence
of this region is highly conserved between K7 and
A52 (Fig. 2), suggesting that this segment may
indeed be involved in protein–protein interactions,but distinct from the mode of recognition seen in the
Bcl-2 family.
Backbone dynamics of K7
15N NMR relaxation measurements were per-
formed on K7 to examine picosecond–nanosecond
backbone dynamics, resulting in 15N R1, R2 and
15N
NOEvalues shown in Fig. 4. Smaller 15NNOEvalues
for residues 8–11 are consistent with a disordered
NH2 terminus obtained in the NMR solution struc-
ture. Moreover, increased R2 relaxation rates are
evident for residues 80–83, 90–91, 94–98, 109–118
and 129 (relaxation data could not be obtained for
residues 85–89, 92–93 and 119–128 because of over-
lap or absent peaks), suggesting conformational
exchange on the millisecond time scale. These resi-
dues are in loop regions and are consistent with
disorder observed in the NMR solution structure
(Fig. 1 and Supplementary Fig. S1).
As discussed previously, the α3–α5 loop of K7
(residues 83–94) lacks regular secondary structure.
Analyses of the chemical shifts of residues in this
loop show no indication of an α-helical conforma-Fig. 4. Backbone dynamics of K7
(a) 15N longitudinal relaxation rates
(R1); (b) 15N transverse relaxation
rates (R2); (c)
15N{1H}NOEs for each
residue in K7. Secondary structured
regions are show as ribbons above
the first panel above and as grey
bleeds on the graphs.
848 Structure of K7tion. Elevated R1 rates and lower
15N{1H} NOE
values measured in the loop 83–94 show that nano-
second time scale internal motions are also present,
suggesting that K7 has substantial flexibility in this
region relative to other viral and cellular Bcl-2
proteins.
Mapping of K7 interactions with human RNA
helicase DDX3
Prompted by the observation that K7 binds to
human RNA helicase DDX3 in VACV-WR infected
cells,8 we mapped the interactions between K7 and
DDX3 using a combination of deletion analyses, in
vitro pull-down assays, co-purification procedures
and NMR. Deletion of the N-terminal ∼166 resi-
dues of DDX3 preceding the core helicase domains
(167–580) eliminated K7 binding (data not shown).
Inclusion of the upstream ‘flanking sequence’ that
corresponds to two short α-helices in Drosophila
Vasa helicase17,20 (DDX3 construct 139–572) simi-
larly did not reconstitute binding to K7, thus poin-
ting to an important epitope in the first 139 residues
of DDX3. This finding was supported by successful
purification of DDX35–167 (fragment 5–167) in com-
plex with K7 by size-exclusion chromatography
(Fig. 5). This region is unique to DDX3 and bears no
significant similarities to other helicases or proteins
in various databases. Inspection of the amino acid
composition of this segment implies a largely un-
structured polypeptide, given the prevalence of
polar and charged amino acids and the presence of
22 Gly residues.Fig. 5. Purification of the K7–DDX3 complex by size-ex
purified together with K7 using a Superdex-75 (sx75) column, a
PAGE analyses of the purification steps, visualized with Coo
following induction of protein expression. Lane 2, affinity-
filtration. Lanes 3–5, fractions from the main peak following sThe residues in K7 that interact with DDX3 were
mapped by a variant of NMR chemical shift map-
ping,21,22 which calculates minimal chemical shift
changes. This strategy was adopted because the two
proteins form a tight complex in slow exchange on
theNMR time scale, and the direction of the chemical
shift changes could not be followed with a titration.
In this case, the minimal chemical shift changes to
translate the peak list for the 15N–1H HSQC spec-
trum of uncomplexed K7 into a peak list compatible
with the spectrum of the K7R/DDX35–167 complex
were calculated (Fig. 6). For signals that have clearly
moved between the free protein and the complex, the
chemical shift difference to the nearest cross peak
places a lower bound on the chemical shift change.
These studies indicated that DDX3 binds across a
shallow groove along α1 and between the ordered
part of the N-terminus and the α5–α6 loop (Fig. 6). In
this figure, the orientation of the molecules are
rotated 180° away from those in Fig. 1, along the
vertical axis. This region corresponds to the homo-
dimerisation interface of N1, which is mediated by
α1 and α6. The negatively charged character of the
corresponding K7 face may preclude dimer forma-
tion through electrostatic repulsions.
Given the apparent non-globular nature of the
N-terminus of DDX3 from sequence analyses, we
hypothesized that K7 binds to a short stretch of
DDX3 polypeptide. A series of 30-residue non-over-
lapping peptides of DDX3 were synthesized to
narrowly define the K7-binding region. The five
DDX3 peptides 1–30, 31–60, 61–90, 91–120 (not
shown) and 121–150 were each synthesized with aclusion chromatography. The DDX35–167 fragment was
s described inMaterials andMethods. Inserted panel: SDS-
massie Brilliant Blue. Lane 1, crude lysate of DDX35–167
purified DDX3 and K7, incubated together prior to gel
x75 gel filtration.
Fig. 6. Identification of the DDX3-binding face of K7 by 1H–15N HSQC chemical shift mapping. The orientation of
these models is rotated 180° along the vertical axis relative to Fig. 1. Left, electrostatic surface map of K7 revealing the
density of negatively charged residues on this face. Right, ribbon model of the DDX3-binding region of K7 deduced from
1H–15N HSQC spectra. Surfaces patches close to residues with a change in the shift metric ΔN0.5 ppm are colored in
magenta. Bottom, a graph of the shift metricΔ for all residues in K7. Secondary-structure elements are shown at the top of
the panel and as grey bleeds on the graph. The sequence of K7 is shown at the bottom of the panel. The values of the shift
metric Δ are shown as a bar chart, with the cutoff region Δb0.5 ppm shown in blue and residues with ΔN=0.5 ppm
shown with their bars colored magenta.
849Structure of K7hexahistidine tag at their N-termini to facilitate Ni2+-
agarose pull-down experiments with untagged K7.
Only DDX3 peptide 61–90 was able to pull-down
K7, revealing an important epitope for K7 binding
in this region (Fig. 7). This segment of DDX3 is
enriched in positively charged residues (Lys+Arg,
six total) and serine residues. Isothermal titration
calorimetry (Fig. 8) revealed a Kd=228 nM for the
interaction between the DDX361–90 peptide and K7,
which is only modestly weaker than the longer
N-terminal fragment DDX35–167 (Kd=109 nM).Discussion
The NMR solution structure of K7 reveals that it
belongs to the Bcl-2 family. Despite this structural
similarity there is no apparent functional conserva-
tion between K7 and the viral and cellular Bcl-2
family members (Fig. 9). In K7, the corresponding
BH3 peptide-binding region is occluded by the
length and orientation of the α2 helix, and the typi-cally shallow groove is filled with aromatic residues.
This would make it impossible for K7 to bind to
helical peptides in a fashion similar to that of Bcl-2
family proteins. It is evident that K7 belongs to a
growing population of small helical ‘immune eva-
sion’ proteins (A52, N1 and M11, M11L) that are
functionally distinct but share an ancestral fold that
is related to the cellular Bcl-2 family. In the case of
N1, M11 and M11L, the capacity to bind BH3 helices
is retained, and they have roles in the modulation of
host apoptosis. K7 described here and the structu-
rally related A52 antagonize host immunity by
forming protein–protein complexes with multiple
cellular partners. K7 binding to a distinct subset of
effectors (e.g., DDX3) may partly be rationalized by
its monomeric state, which opens the possibility of
an additional face for protein–protein interactions
relative to dimeric Bcl-2 family proteins.
Our data suggest that the primary binding site for
K7 is at the N-terminal segment of DDX3 preceding
the core helicase domains. Consistent with this
notion, the fragment DDX31–139 binds to K7 in
Fig. 7. K7 protein is pulled down by the His-tagged
DDX361–90 peptide. Top panel: domain organization of
human RNA helicase DDX3. Peptides corresponding to
the N-terminal region of DDX3 were synthesized with
non-cleavable hexahistidine tags. Bottom panel: each
lane in the SDS-PAGE gel represents a pull-down
experiment using Ni2+-agarose beads. Lane 1, negative
control (no proteins added). Lane 2, negative control,
untagged K7 was incubated with beads. Lane 3, K7 and
DDX31–30 peptide were incubated together. Lane 4, K7
and DDX331–60 peptide. Lane 5, K7 and DDX361–90
peptide. Lane 6, K7 and DDX3121–150 peptide. Protein
bands were visualized by Coomassie Brilliant Blue.
Peptide bands (4 kDa) are too small and weakly staining
to be visible in the 12% SDS-PAGE gel.
850 Structure of K7HEK293T cells, and the region 1–139 is necessary for
the positive effects of DDX3 on ifnb promoter
induction.8 Biochemical and biophysical studies
described here have narrowed an important K7
epitope to the peptide DDX361–90. From an electro-
static point of view, there is compatibility, given that
the pI of DDX361–90 is 9.5, while the pI of K7 is 4.8.
Collectively, these studies point to the negatively
charged face of K7 as the prime candidate for DDX3
binding (Fig. 6). Several aspartate residues on this
face of K7 are not conserved in A52 (Fig. 2), which
may partly explain the inability of A52 to interact
with DDX3 despite significant sequence (and pre-
sumably structural) similarities to K7.
K7 joins a growing list of viral proteins that target
DDX3 to subvert cellular processes for viral replica-
tion. Human immunodeficiency virus 1 (HIV-1) has
been found to hijack cellular DDX3 via interactions
with Rev/CRM-1 to facilitate export of viral mRNA
from the nucleus to the cytosol.23 Poxviruses are
large double-stranded DNAviruses that replicate in
the cytosol and therefore do not require the shuttling
of nascent viral mRNA from the nucleus. It is pos-
sible that different viruses may co-opt distinct regu-
latory functions of DDX3 and may therefore bind to
different regions of the helicase. Consistent with thisidea, the interactions between Rev/CRM-1 and
DDX3 have been roughly mapped to residues 260–
517 of DDX3.23
Due to the emerging importance of viral and
cellular RNA helicases during infection, it has
been suggested that they may represent a new
class of therapeutic targets for structure-based
drug design.9,24 However, our deletion analyses
suggest that poxvirusesmayhijack functions ofDDX3
that are independent of RNA substrate binding and
ATP hydrolysis. Recently published studies in the
laboratory of one of the authors have established a
role for DDX3 in ifnb promoter induction through
direct binding to TBK1/IKKɛ, thus providing a
rationale for the ability of K7 to inhibit interferon
induction via binding to DDX3.8 The critical role of
DDX3 in the activation of TBK1/IKKɛ has been
simultaneously characterized by an independent
group.25 Future structural characterization of the
K7–DDX3 complex, together with biophysical and
functional studies, will enable an understanding of
the molecular basis for K7 antagonism of innate
immune signaling.Materials and Methods
Protein expression and purification
K7 was PCR-amplified from genomic DNA derived
from VACV strain WR, while DDX3 was amplified from
cDNA obtained from peripheral blood monocytes. The
initial K7 construct for bacterial expression was PCR am-
plified from a pCMV-Ha-K7 construct (see primers below)
and inserted into a modified pET vector containing an
N-terminal His-tag and recombinant tobacco etch virus
(rTEV) cleavage site (pHIS-parallel-2, Amp+). The amino
acid sequence following cleavage of the affinity tag,
GAMGSGIQ-[M1-A2-T3…] began with seven non-native
residues prior to Met1 of K7. Since initial NMR spectra
suggested that K7 residues Met1–Tyr7 are flexible, a new
construct was designed to dispense with the presumably
disordered N-terminus. Following rTEV cleavage, the
N-terminally truncated K7 protein contained the non-
native sequence Gly-Ala-Met arising from the cloning site
in the vector, followed by Tyr8-Glu9-Asp10…, etc.
Biophysical and biochemical studies of wild-type full-
length protein were performed using a construct synthe-
sized by GENEART AG (Regensburg, Germany). The
coding region (residues 1–149), optimized for Escherichia
coli expression, was inserted into pET15b at the Nde1/
BamH1 site. The vector contains an N-terminal His-tag,
and following thrombin cleavage, the N-terminus is left
with three non-native residues (Gly-Ser-His) prior to Met1
of K7. DDX3 constructs were PCR-amplified using various
primers corresponding to truncations of the full-length
(662-residue) protein. All DDX3 constructs were cloned
into pET-28b with an N-terminal hexahistidine tag,
thrombin cleavage site, and a kanamycin resistance
marker. In addition to these in-house constructs, custo-
mized genes corresponding to fragments 5–167 of DDX3
were synthesized by GENEART and inserted into the
Nde1/EcoR1 site of pET28b.
The primers for the initial K7 construct were 5′-ccggaat-
tcagatggcgactaaattagattat-3′ (forward) and 5′-acgcgtcgact-
caattcaattt-tttttctag-3′ (reverse). The PCR product was cut
Fig. 8. Calorimetry studies of K7 binding to DDX3. (a) Full-length K7 (400 μM) was injected into DDX35–167 (17 μM) in
the sample cell. Data were fit using Origin software version 7.0 and the Kd was estimated at 109 nM. (b) Hexahistidine-
tagged DDX3 peptide 61–90 (250 μM) was injected into the sample cell containing full-length K7 (30 μM). The Kd was
228 nM, demonstrating that this peptide largely retains its affinity to K7, relative to DDX35–167. The stoichiometry
deduced from data fitting is (a) 1.01 and (b) 0.96.
851Structure of K7with EcoR1 and Sal1 and pasted into amodified pET vector
containing an N-terminal His-tag and rTEV cleavage site
(pHIS-parallel-2, Amp+). A forward primer, 5′-catgccatg-
gcgactaaattagattatgagg-3′, and a reverse primer, 5′-ccgg-
aattctcaattcaattttttttaga-aaaagtatc-3′, were used to amplify
the segment Glu8–Asn149 of K7 into the Nco1/Eco1 site of
the modified pET vector, pHis-parallel-2. DDX3 constructs
were PCR-amplified with forward primer 5′-catgccatgggt-Fig. 9. Viral proteins that adopt the Bcl-2 fold. The
family can be subdivided into two structural groups, those
that have a closed BH3 groove (K7, and likely A52, whose
structure is currently unknown) and N1/M11/M11L,
which have open grooves.catgtggcagtggaaaatgc-3′ (Nco1, fromMet1); 5′-gggaattcca-
tatgagtcatgtggcagtggaaaatg-3′ (Nde1, from Met1); 5′-
gggaattcc-atatgaactcttcagataatcagagt-3′ (Nde1, from
Asn22); 5′-gggaattccatatgagtgattacgatggcattg-gcag-3′
(Nde1, from Ser102). Reverse primers were 5′-cggaattct-
catctggcaccaaaccctccact-3′ (EcoR1, Tyr580); 5′-cggaattct-
caaatgtcatcgtatttctcaaaattaat-3′ (EcoR1, Ile166). All DDX3
constructs were cloned into pET-28b (Kan+ resistance).
Recombinant protein expression was performed in E.
coli BL21(DE3) cells. For 15N,13C and 15N labeling, cells
were grown in minimal salt medium containing 1 g/L
15NH4Cl and 1 g/L
15NH4Cl plus 2 g/L
13C-substituted
glucose respectively. Induction was performed with
0.5 mM IPTG at 37 °C when A600 reached 0.60, and cells
were allowed to grow with vigorous shaking for 3 h. Cells
were harvested at 4000 rpm for 10 min, and pellets were
solubilized in extraction buffer (10 mM Tris–Cl, 300 mM
NaCl, 10 mM imidazole, 10 mM 2-mercaptoethanol, pH
8.0). Following brief sonication, the lysate was applied
over a Ni2+-agarose resin (Chromatrin Inc) and eluted in
extraction buffer supplemented with 200 mM imidazole.
Fractions of K7 were combined and dialyzed overnight
(10 mM Tris–Cl, 150 mM NaCl, 10 mM 2-mercaptoetha-
nol) in the presence of catalytic amounts of rTEV or
thrombin, depending upon the construct. The solution
containing cleaved K7 protein was adjusted to 300 mM
NaCl and 10 mM imidazole and reapplied on a Ni2+-
agarose column to eliminate uncleaved protein and the
rTEV protease (uncleavable N-terminal His-tag). In con-
trast to K7, the eluted DDX3 proteins were highly prone to
852 Structure of K7aggregation following elution from the Ni2+-agarose
columns. In order to stabilize DDX3 proteins, the elution
buffer (10 mM Tris–Cl, 300 mM NaCl, 10 mM imidazole,
10 mM 2-mercaptoethanol) was supplemented with 10%
glycerol.
Gel-filtration chromatography
The complex of K7 and DDX35–167 was purified using a
Superdex-75 column and an ÄKTAbasic FPLC system (GE
Healthcare). Following separate expression and Ni2+-
affinity purification, approximately 3 mg of each protein
was mixed together and the solution was applied to the
FPLC column. The complex was eluted in Tris-buffered
saline (10 mM Tris–Cl, 100 mMNaCl, 1 mM DTT, pH 7.5).
Glycerol addition was not necessary for DDX35–167 fol-
lowing incubation with K7, as the complex was stable for
days at room temperature. The His-tags ahead of K7 and
DDX35–167 were not removed prior to gel filtration in this
experiment.
In vitro pull-down experiments
Peptides corresponding to residues 1–30, 31–60, 61–90,
91–120 and 121–150 were synthesized by EMC Micro-
collections GmbH (Tübingen, Germany). Each peptide
was extended at the N-terminus by a hexahistidine tag
(uncleavable). The wild-type K7 construct used for this
experiment was synthesized by GENEART (see above).
Protein expression was induced at 30 °C and subse-
quently purified using routine protocols. His-tag clea-
vage was facilitated by incubation with thrombin
overnight concomitant with dialysis (10 mM Tris–Cl,
300 mM NaCl, 10 mM imidazole, pH 7.7, supplemented
with 10 mM β-ME). Following brief incubation (30 min)
at room temperature, the salt concentration was raised to
300 mM, and Ni2+-agarose was added to the cleaved
protein and incubated with gentle shaking for 30 min at
4 °C. The untagged K7 protein was eluted using a
gravity column. The peptides (1 mg powder) were dis-
solved in 1 mL extraction buffer, and 20 μL of this
solution was mixed with 30 μg of K7 in a total volume of
1 mL extraction buffer. Ni2+-agarose was added to the
mixture of peptide–K7 (40 μL of a 50% suspension) and
the solutions were incubated at 4 °C with gentle shaking.
The Ni2+-agarose was washed three times with 1 mL
extraction buffer to eliminate loosely bound proteins.
NMR spectroscopy and structure determination
Initial NMR experiments were performed with His-
tagged full-length K7 protein. From these, it was noted
that the chemical shifts of the first few N-terminal residues
were at random coil positions. An N-terminal truncated
construct (K7Δ8) had superiorNMRcharacteristics andwas
chosen for structure determination. Samples of 0.8mM 15N-
and 0.8 mM 15N,13C-labeled K7Δ8 in 10 mM sodium
phosphate, 100 mM NaCl, 10 mM DTT, pH 7.0, 90% H2O/
10% D2O were used for NMR experiments. Spectra were
recorded at 25 °C on a Varian Inova 600 MHz with a room
temperature probe or aVarian Inova 750-MHz spectrometer
equipped with a cryogenic probe. Sequential assignment,
structural restraint and structure calculation procedures are
detailed in Supplementary Methods online.
The minimum changes in chemical shift between the
1H–15N spectra of apo-K7 and the complex K7/DDX3
acquired on 0.1 mM samples of both proteins were calcu-lated by finding for each peak in the apo spectrum the
closest peak in the spectrum of the K7/DDX3 complex
using the distance metric22 Δ=[(δ15Napo/k7r-ddx3)
2+ (5×δ
1Hapo/k7r-ddx3)
2]0.5. The environment of residues with a
ΔN0.5 ppm was then considered to have changed signi-
ficantly and these residues are thus in the interface
between the two proteins. Chemical shift referencing
between the two spectra were verified from the chemical
shifts from the 10% of peaks with the lowest value of Δ.
Isothermal titration calorimetry
Calorimetry was performed using a VP-ITC calorimeter
(Microcal Corp). Due to the instability of DDX35–167, its
concentration was maintained below 50 μM in the cell. In
addition, the titrations were performed in the presence of
10% glycerol. The DDX3 peptide 61–90 was synthesized
with a hexahistidine tag at the N-terminus by EMCMicro-
collections. The sequence of the peptide was HHHHHH-
SSSKDKDAYSSFGSRSDSRGKSSFFSDRGS. The HPLC-
purified peptide was analyzed by mass spectrometry and
judged to be better than 95% pure. The K7 protein used for
calorimetry was expressed from a synthetic gene obtained
from GENEART (see above). Similarly, the construct
DDX35–167 was obtained from GENEART in the pET-28b
vector.
Protein Data Bank accession numbers
Coordinates of K7 have been deposited in the PDB and
BioMagResBank with accession numbers 2k36 and 15740
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